Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
新辅助免疫检查点阻断治疗后,可切除的KRAS突变型肺癌中基于STK11共突变状态的临床和免疫学结果存在差异
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2983
Rosner, Samuel; Connor, Sydney; Sanber, Khaled; Zahurak, Marianna; Zhang, Tianbei; Gurumurthy, Isha; Zeng, Zhen; Presson, Brad; Singh, Dipika; Rayes, Roni; Sivapalan, Lavanya; Pereira, Gavin; Ji, Zhicheng; Thummalapalli, Rohit; Reuss, Joshua E; Broderick, Stephen R; Jones, David R; Deutsch, Julie S; Cottrell, Tricia R; Chaft, Jamie E; Spicer, Jonathan; Taube, Janis; Anagnostou, Valsamo; Brahmer, Julie R; Pardoll, Drew M; Ji, Hongkai; Forde, Patrick M; Marrone, Kristen A; Smith, Kellie N
Checkpoint
肺癌
肿瘤
肿瘤免疫
RAS
STK11
免疫/内分泌